Caplin Point Laboratories Ltd vs Norris Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 2371 as of 11 Jun 11:50 . The P/E Ratio of Caplin Point Laboratories Ltd changed from 12.6 on March 2021 to 28.4 on March 2025 . This represents a CAGR of 17.65% over 5 yearsThe P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 3057 crore on March 2021 to ₹ 15222 crore on March 2025 . This represents a CAGR of 37.86% over 5 yearsThe Market Cap of Norris Medicines Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Caplin Point Laboratories Ltd for the Mar '26 is ₹ 628.52 crore as compare to the Dec '25 revenue of ₹ 576.45 crore. This represent the growth of 9.03% The revenue of Norris Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Caplin Point Laboratories Ltd for the Mar '26 is ₹ 232.6 crore as compare to the Dec '25 ebitda of ₹ 223.35 crore. This represent the growth of 4.14% The ebitda of Norris Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 172.88 crore over 8 quarters. This represents a CAGR of 17.64% The net profit of Norris Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Caplin Point Laboratories Ltd changed from 14.53 % on March 2021 to 13.43 % on March 2025 . This represents a CAGR of -1.56% over 5 yearsThe Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Caplin Point Laboratories Ltd

Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

FAQs for the comparison of Caplin Point Laboratories Ltd and Norris Medicines Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Norris Medicines Ltd?

Market cap of Caplin Point Laboratories Ltd is 17,543 Cr while Market cap of Norris Medicines Ltd is 14 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Norris Medicines Ltd?

The stock performance of Caplin Point Laboratories Ltd and Norris Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Norris Medicines Ltd?

As of June 11, 2026, the Caplin Point Laboratories Ltd stock price is INR ₹2308.0. On the other hand, Norris Medicines Ltd stock price is INR ₹14.0.

How do dividend payouts of Caplin Point Laboratories Ltd and Norris Medicines Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Norris Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.